| Lanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical production EL Ongey, P Neubauer Microbial cell factories 15, 1-16, 2016 | 113 | 2016 |
| Pharmacological and pharmacokinetic properties of lanthipeptides undergoing clinical studies EL Ongey, H Yassi, S Pflugmacher, P Neubauer Biotechnology letters 39, 473-482, 2017 | 69 | 2017 |
| Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity M Narwal, J Koivunen, T Haikarainen, E Obaji, OE Legala, ... Journal of medicinal chemistry 56 (20), 7880-7889, 2013 | 64 | 2013 |
| Bioinspired designs, molecular premise and tools for evaluating the ecological importance of antimicrobial peptides EL Ongey, S Pflugmacher, P Neubauer Pharmaceuticals 11 (3), 68, 2018 | 34 | 2018 |
| Type II thioesterase improves heterologous biosynthesis of valinomycin in Escherichia coli J Li, J Jaitzig, L Theuer, OE Legala, RD Süssmuth, P Neubauer Journal of Biotechnology 193, 16-22, 2015 | 29 | 2015 |
| Heterologous biosynthesis, modifications and structural characterization of Ruminococcin-A, a lanthipeptide from the gut bacterium Ruminococcus gnavus E1, in Escherichia coli EL Ongey, RT Giessmann, M Fons, J Rappsilber, L Adrian, P Neubauer Frontiers in Microbiology 9, 393680, 2018 | 28 | 2018 |
| Bioprocess development for lantibiotic ruminococcin-A production in Escherichia coli and kinetic insights into LanM enzymes catalysis EL Ongey, L Santolin, S Waldburger, L Adrian, SL Riedel, P Neubauer Frontiers in Microbiology 10, 470923, 2019 | 10 | 2019 |
| Incorporation of non-canoncical amino acids into recombinant human proteins heterologously expressed in E. coli by bioprocess parturbations E Ongey E. Ongey, 2014 | | 2014 |
| Reconstructing the biosynthetic machinery of Ruminococcin A, a lanthipeptide identified from a strictly anaerobic Gram positive bacteria, in E. coli OE Legala, M Fons, P Neubauer | | |
Peter NeubauerTU Berlin, Professor of Bioprocess EngineeringVerified email at tu-berlin.de
